Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants

NCT01392469 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Imatinib
DRUG: Sildenafil
DRUG: Bosentan

Sponsor

Novartis Pharmaceuticals